Assignment

Vinge has advised Pandox in connection with a directed share issue

March 30, 2017

Vinge has advised Pandox Aktiebolag (publ) in connection with a directed share issue of 7,499,99 class B shares at a subscription price of SEK 135 per share. Through the share issue, Pandox will obtain approximately SEK 1,012 million. The subscription price was determined through an accelerated book-building process. The share issue is directed to selected Swedish and international institutional investors. The purpose of the share issue is to, in a timely and cost efficient manner, enable a capital raising to finance acquisitions and thereby increase the company’s financial flexibility and mandate for continued value creation.
 
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. The company’s shares are admitted to trading on Nasdaq Stockholm.
 
Vinge’s team primarily consisted of Jesper Schönbeck, Erik Sjöman, Nils Fredrik Dehlin, Tora Hansjons and Michaela Cronemyr.

Related

Vinge advises EQT in connection with the sale of Eton

Vinge has advised EQT VII in connection with its sale of Eton to a consortium of private investors.
July 01, 2025

Vinge advises Triton in connection with the acquisition of Prenax

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.
July 01, 2025

Vinge advises Impilo on the establishment of Impilo Healthcare

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Healthcare. The fund will have EUR 320m in commitments.
July 01, 2025